President and Chief Executive Officer @ Omniome (September 2017 - January 2021)
Lifecycle Leader, Site Head and Chief Operations Officer - Ariosa @ Roche Molecular Solutions (January 2015 - January 2017)
President and Chief Operations Officer @ (January 2014 - January 2015)
Senior Vice President and General Manager, Dermatology @ Valeant Pharmaceuticals Intl (January 2009 - January 2013)
Vice President, Marketing @ (January 2006 - December 2008)
Director, Global Commercial Leader and Director, Marketing Excellence @ (January 2001 - January 2006)
Executive Director, Business Development @ (January 1997 - January 2001)
Senior Associate, Management Consultant @ (January 1993 - January 1997)
Specialty Sales Representative @ Eli Lilly and Company (January 1988 - January 1992)
Dave Mullarkey Education
Cornell University
B.S. (Applied Economics & Business Management - Dyson School of Management)
Northwestern University - Kellogg School of Management
M.B.A. (Marketing and Strategy)
Dave Mullarkey Summary
Dave Mullarkey, based in Menlo Park, CA, US, is currently a Chief Executive Officer at ClearNote Health. Dave Mullarkey brings experience from previous roles at Omniome (Acquired by Pacific Biosciences NASDAQ: PACB for $800M), Roche Molecular Solutions, Ariosa Diagnostics (Acquired by Roche OTCQX: RHHBY for $625M) and Valeant Pharmaceuticals International (now Bausch Health NYSE: BHC). Dave Mullarkey holds a B.S. in Applied Economics & Business Management - Dyson School of Management @ Cornell University. Dave Mullarkey has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Dave Mullarkey?
Find contact details for 700 million professionals.